The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Regulation of the p53 Tumor Suppressor Protein
Open accessAbstract
c-Jun N-terminal kinase Mutations in the p53 tumor suppressor gene occur in about 50% of all human tumors, making it the most frequent target for genetic alterations in cancer (for recent reviews on p53 see Refs. 1Hansen R. Oren M. Curr. Opin. Genet. Dev. 1997; 7: 46-51Crossref PubMed Scopus (206) Google Scholar, 2Levine A.J. Cell. 1997; 88: 323-331Abstract Full Text Full Text PDF PubMed Scopus (6697) Google Scholar, 3Agarwal M.L. Taylor W.R. Chernov M.V. Chernova O.B. Stark G.R. J. Biol. Chem. 1998; 273: 1-4Abstract Full Text Full Text PDF PubMed Scopus (646) Google Scholar, 4Almog N. Rotter V. Biochim. Biophys. Acta. 1998; 1378: R43-R54PubMed Google Scholar, 5Prives C. Hall P.A. J. Pathol. 1999; 187: 112-126Crossref PubMed Scopus (1225) Google Scholar). Such mutations probably facilitate carcinogenesis primarily through abrogating the tumor suppressor activities of the wild type p53 protein, although at least some forms of tumor-associated mutant p53 proteins may also contribute overt oncogenic activities (gain of function). Excessive wild type p53 activity gives rise to a variety of cellular outcomes, most notably cell cycle arrest and apoptosis. These cellular effects of wild type p53 can reduce cancer incidence through elimination of cancer-prone cells from the replicative pool. However, such effects might become very undesirable if occurring in a normal, unperturbed cell. p53 activity must therefore be kept under tight control, being unleashed only when a cell accumulates lesions that may otherwise drive it into a cancerous state. The signals and mechanisms that regulate p53 activity, maintaining it at low levels under normal conditions and turning it on in cancer-prone cells, are the subject of this review.p53-activating SignalsUnder normal conditions, p53 is most probably latent. Consequently, it does not interfere with cell cycle progression and cell survival. Moreover, p53 knock-out mice appear in most cases to undergo proper development and maturation (6Donehower L.A. Harvey M. Slagle B.L. Mcarthur M.J. Montgomery C.A. Butel J.S. Bradley A. Nature. 1992; 356: 215-221Crossref PubMed Scopus (4009) Google Scholar), suggesting that p53 is not essential for the normal performance of cells within the body. However, a variety of conditions can lead to rapid induction of p53 activity (Fig. 1). The common denominator of these conditions is that they represent various types of stress, which are likely to favor the emergence of cancer-bound cells. Such conditions include direct DNA damage (7Kastan M.B. Onyekwere O. Sidransky D. Vogelstein B. Craig R.W. Cancer Res. 1991; 51: 6304-6311PubMed Google Scholar, 8Maltzman W. Czyzyk L. Cell. Biol. PubMed Scopus Google Scholar, A. PubMed Scopus Google damage to in the proper and of the cellular genetic the C.A. C.A. PubMed Scopus Google L.A. A. Dev. PubMed Scopus Google Scholar), C. A.J. Nature. PubMed Scopus Google Scholar), A. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar), and to A. PubMed Scopus Google Scholar). of is a the rapid induction of p53 activity in to damage to that cells such damage are p53 may also to DNA M.L. A.J. Google Scholar, R. D. Rotter V. 1999; PubMed Scopus Google Scholar). The of p53 in maintaining it the of the Nature. 1992; PubMed Scopus Google Scholar). p53 activity is a variety of oncogenic and D. PubMed Scopus Google Scholar, M. D. Cell. 1997; 88: Full Text Full Text PDF PubMed Scopus Google Scholar, M. Dev. 7: PubMed Scopus Google Scholar, A. A. M. J. B. Oren M. J. 1999; PubMed Scopus Google Scholar), a direct oncogenic and the tumor suppressor of p53 of p53 induction of the p53 through alterations in the p53 in the of of the p53 gene a if in such Consequently, the of the p53 gene very recent not that the of is it that p53 levels rise A.J. Nature. PubMed Scopus Google Scholar). rise may be of the of for in the p53 D. Oren M. M. J. Google to the of the p53 gene to the and to be D. B. J. Rotter V. Google Scholar). The induction of and may at However, it does DNA and are at of DNA damage and rise to cancer-prone cells. of p53 levels under such conditions the cells in a of is DNA damage stress, p53 and does not interfere with normal cellular However, if conditions that for a p53 the of levels of p53 that such a be rapid and of p53 of cells to signals can lead within a to a in p53 some this can be of the p53 probably of a through the of this J. PubMed Scopus Google Scholar). also that p53 can p53 through to J. C. W. J. PubMed Scopus Google Scholar, C.A. Cell. Biol. 1997; PubMed Scopus Google Scholar). it is that the of p53 in to through is the in the of p53 is a very protein, turning with a a A. M. C.A. Oren M. Cell. Biol. PubMed Scopus Google Scholar). to DNA damage and types of stress, p53 is (7Kastan M.B. Onyekwere O. Sidransky D. Vogelstein B. Craig R.W. Cancer Res. 1991; 51: 6304-6311PubMed Google Scholar, 8Maltzman W. Czyzyk L. Cell. Biol. PubMed Scopus Google Scholar). rapid in p53 a for is in cells with is mos
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Self-citationParticipation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
mdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Self-citationRescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899
UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
Maltzman, W., & Czyzyk, L. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1689 · Cited by 893
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
Debbas, M., & White, E. (1993) · Genes & Development · doi:10.1101/gad.7.4.546 · Cited by 871
Mediation of c-Myc-Induced Apoptosis by p53
Hermeking, H., & Eick, D. (1994) · Science · doi:10.1126/science.8091232 · Cited by 739
Agarwal, M. L., Taylor, W. R., Chernov, M. V., Chernova, O. B., & Stark, G. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.1 · Cited by 726
Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
Honda, R., & Yasuda, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.22 · Cited by 724
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
In vivo ubiquitination and proteasome-mediated degradation of p53(1).
Maki, C. G., Huibregtse, J. M., & Howley, P. M. (1996) · PubMed · Cited by 645
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615
E1A signaling to p53 involves the p19ARFtumor suppressor
de Stanchina, E., McCurrach, M. E., Zindy, F., Shieh, S.-Y., Ferbeyre, G., Samuelson, A. V., Prives, C., Roussel, M. F., Sherr, C. J., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.15.2434 · Cited by 609
Functions of the MDM2 oncoprotein
Freedman, D. A., Wu, L., & Levine, A. J. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050273 · Cited by 577
Linke, S. P., Clarkin, K. C., Di Leonardo, A., Tsou, A., & Wahl, G. M. (1996) · Genes & Development · doi:10.1101/gad.10.8.934 · Cited by 538
Growth regulation of a cellular tumour antigen, p53, in nontransformed cells
Reich, N. C., & Levine, A. J. (1984) · Nature · doi:10.1038/308199a0 · Cited by 494
Forrester, K., Ambs, S., Lupold, S. E., Kapust, R. B., Spillare, E. A., Weinberg, W. C., Felley-Bosco, E., Wang, X. W., Geller, D. A., Tzeng, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2442 · Cited by 469
ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins
Waterman, M. J. F., Stavridi, E. S., Waterman, J. L. F., & Halazonetis, T. D. (1998) · Nature Genetics · doi:10.1038/542 · Cited by 460
Regulation of p53 function and stability by phosphorylation.
Ashcroft, M., Kubbutat, M. H. G., & Vousden, K. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1751 · Cited by 452
p53 Transcriptional Activation Mediated by Coactivators TAF II 40 and TAF II 60
Thut, C. J., Chen, J.-L., Klemm, R., & Tjian, R. (1995) · Science · doi:10.1126/science.7809597 · Cited by 439
Phosphorylation of p53 Serine 15 Increases Interaction with CBP
Lambert, P. F., Kashanchi, F., Radonovich, M. F., Shiekhattar, R., & Brady, J. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.33048 · Cited by 423
Huang, L. C., Clarkin, K. C., & Wahl, G. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4827 · Cited by 384
p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.
Rogel, A., Popliker, M., Webb, C. G., & Oren, M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2851 · Cited by 378
Self-citationCritical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2
Unger, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1805 · Cited by 367
Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage.
Smith, M. L., Chen, I. T., Zhan, Q., O'Connor, P. M., & Fornace, A. J. (1995) · PubMed · Cited by 364
Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo
Böttger, A., Böttger, V., Sparks, A., Liu, W.-L., Howard, S. F., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00374-5 · Cited by 363
mdm-2 Inhibits the G1 Arrest and Apoptosis Functions of the p53 Tumor Suppressor Protein
Chen, J., Wu, X., Lin, J., & Levine, A. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2445 · Cited by 350
JNK targets p53 ubiquitination and degradation in nonstressed cells
Fuchs, S. Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S. N., & Ronai, Z. (1998) · Genes & Development · doi:10.1101/gad.12.17.2658 · Cited by 341
Proteolytic Cleavage of Human p53 by Calpain: a Potential Regulator of Protein Stability
Kubbutat, M. H. G., & Vousden, K. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.460 · Cited by 307
Human TAFII31 protein is a transcriptional coactivator of the p53 protein.
Lu, H., & Levine, A. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.5154 · Cited by 301
Shieh, S.-Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1815 · Cited by 300
Negative feedback regulation of wild-type p53 biosynthesis.
Mosner, J., Mummenbrauer, T., Bauer, C., Sczakiel, G., Grosse, F., & Deppert, W. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00123.x · Cited by 286
Repression of p53-mediated transcription by MDM2: a dual mechanism
Thut, C. J., Goodrich, J. A., & Tjian, R. (1997) · Genes & Development · doi:10.1101/gad.11.15.1974 · Cited by 272
The mdm-2 gene is induced in response to UV light in a p53-dependent manner.
Perry, M. E., Piette, J., Zawadzki, J. A., Harvey, D., & Levine, A. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11623 · Cited by 247
(1997) · PubMed · Cited by 243
Excess beta -catenin promotes accumulation of transcriptionally active p53
Damalas, A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3054 · Cited by 241
Lundgren, K., Montes de Oca Luna, R., McNeill, Y. B., Emerick, E. P., Spencer, B., Barfield, C. R., Lozano, G., Rosenberg, M. P., & Finlay, C. A. (1997) · Genes & Development · doi:10.1101/gad.11.6.714 · Cited by 235
Cell type-specific inhibition of p53-mediated apoptosis by mdm2.
Haupt, Y., Barak, Y., & Oren, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00504.x · Cited by 228
Self-citationp53; from inductive signal to cellular effect
Hansen, R., & Oren, M. (1997) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(97)80108-6 · Cited by 213
Self-citationShaw, P., Freeman, J., Bovey, R., & Iggo, R. D. (1996) · PubMed · Cited by 202
p53-Independent Role of MDM2 in TGF-β1 Resistance
Sun, P., Dong, P., Dai, K., Hannon, G. J., & Beach, D. (1998) · Science · doi:10.1126/science.282.5397.2270 · Cited by 195
Juven-Gershon, T., & Oren, M. (1999) · Molecular Medicine · doi:10.1007/bf03402141 · Cited by 194
Self-citationMultisite Phosphorylation and the Integration of Stress Signals at p53
Meek, D. W. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(97)00119-8 · Cited by 185
c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
Reisman, D., Elkind, N. B., Roy, B., Beamon, J., & Rotter, V. (1993) · PubMed · Cited by 182
Wu, L., & Levine, A. J. (1997) · Molecular Medicine · doi:10.1007/bf03401691 · Cited by 172
Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells.
Shaulsky, G., Ben‐Ze'ev, A., & Rotter, V. (1990) · PubMed · Cited by 166
Stress-activated kinases regulate protein stability
Fuchs, S. Y., Fried, V. A., & Ronai, Z. A. (1998) · Oncogene · doi:10.1038/sj.onc.1202184 · Cited by 156
DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
Blattner, C., Tobiasch, E., Litfen, M., Rahmsdorf, H. J., & Herrlich, P. (1999) · Oncogene · doi:10.1038/sj.onc.1202480 · Cited by 151
Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery
Offer, H., Wolkowicz, R., Matas, D., Blumenstein, S., Livneh, Z., & Rotter, V. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00505-0 · Cited by 150
Landers, J. E., Haines, D. S., STRAUSS, J. F., & George, D. L. (1994) · PubMed · Cited by 143
Translational regulation of human p53 gene expression.
Fu, L., Minden, M. D., & Benchimol, S. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00812.x · Cited by 138
Covalent and noncovalent modifiers of the p53 protein
Jayaraman, L., & Prives, C. L. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050271 · Cited by 132
Leri, A., Liu, Y., Claudio, P. P., Kajstura, J., Wang, X., Wang, S., Kang, P., Malhotra, A., & Anversa, P. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65302-3 · Cited by 123
Bayle, J. H., Elenbaas, B., & Levine, A. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5729 · Cited by 119
Hupp, T. R., & Lane, D. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.18165 · Cited by 108
Induction of Mdm2 and enhancement of cell survival by bFGF
Shaulian, E., Resnitzky, D., Shifman, O., Blandino, G., Amsterdam, A., Yayon, A., & Oren, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201453 · Cited by 102
Self-citationAnalysis of the degradation function of Mdm2.
Kubbutat, M. H. G., Ludwig, R., Levine, A. J., & Vousden, K. H. (1999) · PubMed · Cited by 102
p53-dependent Induction of WAF1 by Heat Treatment in Human Glioblastoma Cells
Ohnishi, T., Wang, X., Ohnishi, K., Matsumoto, H., & Takahashi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.24.14510 · Cited by 96
Nature of G1/S cell cycle checkpoint defect in ataxia-telangiectasia.
Khanna, K. K., Beamish, H., Yan, J., Hobson, K., Williams, R. T., Dunn, I. S., & Lavin, M. F. (1995) · PubMed · Cited by 90
Protein-binding elements in the promoter region of the mouse p53 gene.
Ginsberg, D., Oren, M., Yaniv, M., & Piette, J. (1990) · PubMed · Cited by 73
Self-citationCytoplasmic p53 Polypeptide Is Associated with Ribosomes
Fontoura, B. M. A., Atienza, C. A., Sorokina, E. A., Morimoto, T., & Carroll, R. B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3146 · Cited by 65
Regulation of p53 protein function through alterations in protein-folding pathways
Hupp, T. R. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050272 · Cited by 58
Wolkowicz, R., Peled, A., Elkind, N. B., et al. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6842 · Cited by 25
Cellular senescence and cancer
(1999) · doi:10.1002/(sici)1096-9896(199901)187:1
Research works printed but not linked: 16
- Almog, 1998, Biochim. Biophys. Acta, 1378, R43
- Prives, 1999, J. Pathol., 187, 112, 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3 · doi:10.1002/(sici)1096-9896(199901)187:1<112::aid-path250>3.0.co;2-3
- Kastan, 1991, Cancer Res., 51, 6304
- Maltzman, 1984, Mol. Cell. Biol., 4, 1689
- Smith, 1995, Oncogene, 10, 1053
- Ginsberg, 1990, Oncogene, 5, 1285
- Reisman, 1993, Cell Growth Differ., 4, 57
- Rogel, 1985, Mol. Cell. Biol., 5, 2851
- Shaulsky, 1990, Oncogene, 5, 1707
- Lozano, 1998, Biochim. Biophys. Acta, 1377, M55
- Landers, 1994, Oncogene, 9, 2745
- Maki, 1996, Cancer Res., 56, 2649
- Khanna, 1995, Oncogene, 11, 609
- Mayo, 1997, Cancer Res., 57, 5013
- Kubbutat, 1999, Cell Growth Differ., 10, 87
- Shaw, 1996, Oncogene, 12, 921
Cited by
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
Vermeulen, K., Van Bockstaele, D. R., & Berneman, Z. N. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00266.x · Cited by 1,773
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression
Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J., & Strasser, A. (2018) · Cell Death & Differentiation · doi:10.1038/cdd.2017.169 · Cited by 1,395
PUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells
Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., & Vogelstein, B. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00213-1 · Cited by 1,280
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Metadata
- Authors
- Oren, M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 274
- Issue
- 51
- Pages
- 36031-36034
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2148958834
- Cited by
- 564
- References
- 89
- FWCI
- 21.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7617 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.